Literature DB >> 5931012

Failure of epsilon-aminocaproic acid in the treatment of scleroderma.

A P Hall, J T Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5931012      PMCID: PMC2453371          DOI: 10.1136/ard.25.2.175

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS.

Authors:  W M SWEENEY
Journal:  Am J Med Sci       Date:  1965-05       Impact factor: 2.378

2.  Antifibrinolytic drug in treatment of progressive systemic sclerosis.

Authors:  J ROTSTEIN; M GILBERT; I ESTRIN
Journal:  JAMA       Date:  1963-05-11       Impact factor: 56.272

3.  Morning stiffness in rheumatoid arthritis.

Authors:  J T SCOTT
Journal:  Ann Rheum Dis       Date:  1960-12       Impact factor: 19.103

4.  ON THE CLINICAL RECOGNITION OF STRUCTURAL DISEASE OF THE PERIPHERAL VESSELS.

Authors:  G W Pickering
Journal:  Br Med J       Date:  1933-12-16
  4 in total
  1 in total

1.  Failure of low molecular weight dextran infusions in scleroderma.

Authors:  J A Kirk; A S Dixon
Journal:  Ann Rheum Dis       Date:  1969-01       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.